(PCRX) Pacira Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Pacira Pharmaceuticals | (PCRX) share price targets
Complete technical analysis of Pacira Pharmaceuticals (PCRX) by charts plus indicators, forecast predictions and share price targets for Pacira Pharmaceuticals (PCRX)
Pacira Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Pacira Pharmaceuticals is 1178570
| Date | Daily Closing Price | Open | High | Low | Volume |
| 16 Fri Jan 2026 | 19.16 | 20.51 | 20.84 | 18.92 | 1.007 times |
| 15 Thu Jan 2026 | 20.65 | 22.35 | 22.56 | 20.50 | 2.108 times |
| 14 Wed Jan 2026 | 22.24 | 21.64 | 22.53 | 21.35 | 0.875 times |
| 13 Tue Jan 2026 | 21.60 | 22.91 | 22.95 | 21.54 | 0.84 times |
| 12 Mon Jan 2026 | 22.93 | 23.66 | 23.85 | 22.79 | 0.565 times |
| 09 Fri Jan 2026 | 23.53 | 24.64 | 24.91 | 22.51 | 2.071 times |
| 08 Thu Jan 2026 | 26.02 | 25.87 | 26.35 | 25.52 | 0.698 times |
| 07 Wed Jan 2026 | 26.00 | 25.45 | 26.48 | 25.44 | 0.771 times |
| 06 Tue Jan 2026 | 25.31 | 25.10 | 25.66 | 24.85 | 0.454 times |
| 05 Mon Jan 2026 | 25.10 | 24.24 | 25.63 | 24.23 | 1.004 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 20, for a target of 22.5 or 24.58
Share price targets for Pacira Pharmaceuticals (PCRX)
| Target Type | Value |
| Downside Target | 18.92 |
| Upside Target | 19.84 |
| Upside Target | 20.32 |
| Upside Target | 22.51 |
| Upside Target | 23.29 |
| Upside Target | 23.85 |
| Upside Target | 25.48 |
| Upside Target | 26.81 |
| Upside Target | 26.99 |
| Upside Target | 27.16 |
| Upside Target | 27.64 |
Intraday share price targets for Pacira Pharmaceuticals (PCRX)
| Target Type | Value |
| Downside Intraday Target | 17.44 |
| Downside Intraday Target | 15.71 |
| Upside Intraday Target | 22.37 |
| Upside Intraday Target | 25.57 |
| Upside Intraday Target | 20.64 |
Weekly technical analysis of Pacira Pharmaceuticals (PCRX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 16 Fri Jan 2026 | 19.16 | 23.66 | 23.85 | 18.92 | 1.079 times |
| 09 Fri Jan 2026 | 23.53 | 24.24 | 26.48 | 22.51 | 2.575 times |
| 02 Fri Jan 2026 | 24.46 | 26.51 | 26.81 | 24.20 | 1.049 times |
| 26 Fri Dec 2025 | 26.51 | 26.20 | 26.99 | 25.56 | 0.335 times |
| 19 Fri Dec 2025 | 26.35 | 26.29 | 27.16 | 25.48 | 1.347 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Pacira Pharmaceuticals (PCRX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 16 Fri Jan 2026 | 19.16 | 26.07 | 26.81 | 18.92 | 0.706 times |
| 31 Wed Dec 2025 | 25.88 | 23.49 | 27.16 | 23.29 | 1.324 times |
| 28 Fri Nov 2025 | 23.57 | 21.78 | 24.95 | 20.32 | 1.111 times |
| 31 Fri Oct 2025 | 21.38 | 25.80 | 26.05 | 19.84 | 1.021 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Pacira Pharmaceuticals (PCRX)
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Pacira Pharmaceuticals in short term and the sell signal is strong.
Pacira Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Pacira Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Pacira Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.81 and Pacira Pharmaceuticals (PCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Pacira Pharmaceuticals (PCRX) stock. Volume based technical analysis of Pacira Pharmaceuticals (PCRX) stock is negative.
Pacira Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Pacira Pharmaceuticals ( (PCRX) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Pacira Pharmaceuticals in short term and the sell signal is strong.
Pacira Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Pacira Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Pacira Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.81 and Pacira Pharmaceuticals (PCRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Pacira Pharmaceuticals (PCRX) stock. Volume based technical analysis of Pacira Pharmaceuticals (PCRX) stock is negative.
Pacira Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.